These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 502407)

  • 21. [Treatment of acromegaly with bromocriptine (CB 154)].
    Schwinn G; Dirks H; Köbberling J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1896-9. PubMed ID: 801095
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of CB-154 administration in acromegaly].
    Nakagawa K; Obara T
    Horumon To Rinsho; 1977 Dec; 25(12):1274-6. PubMed ID: 598017
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both].
    Barceló B; Pérez C; Dávila N; Lucas T; Salto L; Alcañiz J
    Med Clin (Barc); 1983 May; 80(17):735-41. PubMed ID: 6621120
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
    [No Abstract]   [Full Text] [Related]  

  • 27. [Endocrinological aspects of the dopaminergic control of somatotropin in patients with acromegaly].
    Gragnoli G; Martinelli G; Tanganelli I; Signorini AM; Pallassini A
    Boll Soc Ital Biol Sper; 1977 Oct; 53(19):1620-6. PubMed ID: 607965
    [No Abstract]   [Full Text] [Related]  

  • 28. Bromocriptine treatment of acromegaly: possible dose dependency of the tumor size-reducing effect.
    Gross DJ; Halperin Y; Gomori JM; Glaser B
    Isr J Med Sci; 1989 May; 25(5):256-60. PubMed ID: 2498229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of acromegaly with bromocriptine (Parlodel)].
    Eskildsen PC
    Ugeskr Laeger; 1978 May; 140(22):1296. PubMed ID: 653875
    [No Abstract]   [Full Text] [Related]  

  • 30. Bromocriptine and acromegaly: therapeutic implications.
    Brooks AP; Stephen PJ; Nairn IM; Strong JA
    J R Soc Med; 1979 Aug; 72(8):562-4. PubMed ID: 552555
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM; Wass JA
    Med J Aust; 1978 Nov; 2(3 Suppl):31-3. PubMed ID: 745579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of acromegaly with bromocriptine.
    Sachdev Y; Chatterji JC; Gopal K
    J Assoc Physicians India; 1979 Aug; 27(8):741-7. PubMed ID: 120367
    [No Abstract]   [Full Text] [Related]  

  • 35. [100 years of acromegaly: general lessons about a rare disease].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1986 May; 130(20):902-4. PubMed ID: 2873513
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic effect of CB-154 in acromegaly].
    Miyashita M; Kaneko K; Yamada Y
    Horumon To Rinsho; 1977 Dec; 25(12):1306-7. PubMed ID: 598030
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy].
    Benker G; Zäh W; Günnewig H; Hackenberg K; Werner U; Reinwein D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1899-901. PubMed ID: 801096
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of blood somatotropin and phosphorus levels after administration of 2-bromo-alpha-ergocryptine].
    Romiti A; Martelletti P; Giacovazzo M
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2257-9. PubMed ID: 754723
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic experience with CB-154 in acromegaly].
    Abe K; Shigemasa C; Takeda A; Ikeda T; Kitahara K
    Horumon To Rinsho; 1977 Dec; 25(12):1338-40. PubMed ID: 598040
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of CB-154 in the treatment of acromegaly].
    Asai T; Kawai S; Takazawa A; Awaya M; Nihei R
    Horumon To Rinsho; 1977 Dec; 25(12):1320-3. PubMed ID: 598033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.